Kadian

 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
BACKGROUND For a number of fiscal and practical reasons, data on heroin use have been of poor quality, which has hampered the… Expand
Is this relevant?
2011
2011
Morphine sulfate and naltrexone hydrochloride extended release capsules (EMBEDA®, King Pharmaceuticals®, Inc., Bristol, TN… Expand
  • figure 2
  • table 1
  • table 2
  • table 3
Is this relevant?
Review
2009
Review
2009
Although most extended-release morphine formulations are indicated for use once-daily (q24h) or twice-daily (q12h), KADIAN… Expand
Is this relevant?
2008
2008
UNLABELLED The recent withdrawal of hydromorphone hydrochloride extended-release capsules (Palladone; Purdue Pharma L.P… Expand
Is this relevant?
Review
2008
Review
2008
Chronic pain, one of the most common reasons for which patients seek medical attention, is defined as pain that persists beyond… Expand
Is this relevant?
2008
2008
llicit use of prescription opioids has caused need for products that discourage abuse. ALO-01 capsules, an abuse-deterrent… Expand
Is this relevant?
2007
2007
OBJECTIVES This study describes the development of a systematic approach to the analysis of Internet chatter as a means of… Expand
Is this relevant?
Review
2005
Review
2005
The long-term use of sustained-release morphine for chronic pain was examined by reviewing charts from 68 patients taking Kadian… Expand
Is this relevant?
1997
1997
SummaryKadian™ is an oral formulation of sustained-release morphine sulfate pellets contained in a gelatin capsule, indicated for… Expand
Is this relevant?